Trials / Not Yet Recruiting
Not Yet RecruitingNCT06952270
Effects of Two Strength Exercise Programs on Upper Limb Functionality in Breast Cancer
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- University of Vigo · Academic / Other
- Sex
- Female
- Age
- 25 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this experimental study is to evaluate the effect of a therapeutic exercise program based on upper limb plyometric exercises in breast cancer patients and breast cancer survivors to determine changes in upper limb functionality. The main question it aims to answer is: Does upper limb plyometric strength exercise improve upper limb dysfunctions in breast cancer patients and survivors? The researchers will compare the effects of plyometric exercise with the effects of strength training exercise to determine whether plyometric exercise improves shoulder dysfunctions in breast cancer patients and survivors. Participants from the Pontevedra group will undergo the intervention using plyometric exercise (Experimental Group), while those from the Vigo group will perform strength training exercise (Control Group). They will complete two sessions per week for six weeks. Outcome variables related to upper limb functionality will be assessed at baseline and after the intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | plyometric exercise | Upper limb plyometric exercise (proprioceptive neuromuscular facilitation of extensor and flexor pattern, external rotation exercise at 90º-90º, chest throw, external rotation and overhead and wall flexion). |
| OTHER | Strength training exercise | Strength training exercises (Squats, Stair climbing and jumps, Bench Press, Push-ups, Core Exercises (Plank, Bridge)). |
Timeline
- Start date
- 2025-05-02
- Primary completion
- 2025-06-01
- Completion
- 2025-07-01
- First posted
- 2025-04-30
- Last updated
- 2025-04-30
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06952270. Inclusion in this directory is not an endorsement.